While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Much of the recent conversation around continuous glucose monitors has focused on expanding the technology beyond the traditional user pool, which has long centered on people with Type 1 diabetes. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback